EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases

Susana Neves-Zaph, Chanchala Kaddi

Clinical Pharmacology & Therapeutics · 2024

DOI: 10.1002/cpt.3451 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Susana Neves-Zaph und 1 weiteren Autor:innen. Beteiligte Einrichtung: Translational Disease Modeling, Translational Medicine and Early Development, Sanofi US, Bridgewater, New Jersey, USA. Hauptthemen laut MEDLINE: Rare Diseases, Drug Development. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rare diseases, affecting millions globally, present significant drug development challenges. This is due to the limited patient populations and the unique pathophysiology of these diseases, which can make traditional clinical trial designs unfeasible. Quantitative Systems Pharmacology (QSP) models offer a promising approach to expedite drug development, particularly in rare diseases. QSP models provide a mechanistic representation of the disease and drug response in virtual patients that can complement routinely applied empirical modeling and simulation approaches. QSP models can generate digital twins of actual patients and mechanistically simulate the disease progression of rare diseases, accounting for phenotypic heterogeneity. QSP models can also support drug development in various drug modalities, such as gene therapy. Impactful QSP models case studies are presented here to illustrate their value in supporting various aspects of drug development in rare indications. As these QSP model applications continue to mature, there is a growing possibility that they could be more widely integrated into routine drug development steps. This integration could provide a robust framework for addressing some of the inherent challenges in rare disease drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesDrug DevelopmentHumansSystems BiologyNetwork PharmacologyModels, BiologicalComputer Simulation

Autor:innen und Institutionen

  • Translational Disease Modeling, Translational Medicine and Early Development, Sanofi US, Bridgewater, New Jersey, USA.

Zitieren

APA

Neves-Zaph, S., & Kaddi, C. (2024). Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3451

Vancouver

Neves-Zaph S, Kaddi C. Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3451

BibTeX
@article{NevesZaph2024,
  author = {Neves-Zaph, Susana and Kaddi, Chanchala},
  title = {Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1002/cpt.3451}
}
Kostenlos starten →